357 related articles for article (PubMed ID: 26131690)
21. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].
Hundahl SA; Fleming ID; Fremgen AM; Menck HR
Cancer; 1998 Dec; 83(12):2638-48. PubMed ID: 9874472
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
[TBL] [Abstract][Full Text] [Related]
23. Ultrasonographic Characteristics of the Follicular Variant Papillary Thyroid Cancer According to the Tumor Size.
Jeon EJ; Jeong YJ; Park SH; Cho CH; Shon HS; Jung ED
J Korean Med Sci; 2016 Mar; 31(3):397-402. PubMed ID: 26955240
[TBL] [Abstract][Full Text] [Related]
24. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
[TBL] [Abstract][Full Text] [Related]
25. An Update on the Risk of Lymph Node Metastasis for the Follicular Variant of Papillary Thyroid Carcinoma with the New Diagnostic Paradigm.
Sowder AM; Witt BL; Hunt JP
Head Neck Pathol; 2018 Mar; 12(1):105-109. PubMed ID: 28647794
[TBL] [Abstract][Full Text] [Related]
26. Population-based outcomes for pediatric thyroid carcinoma.
Shapiro NL; Bhattacharyya N
Laryngoscope; 2005 Feb; 115(2):337-40. PubMed ID: 15689762
[TBL] [Abstract][Full Text] [Related]
27. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
28. Factors related to mortality in patients with papillary and follicular thyroid cancer in long-term follow-up.
de Melo TG; Zantut-Wittmann DE; Ficher E; da Assumpção LV
J Endocrinol Invest; 2014 Dec; 37(12):1195-200. PubMed ID: 25037473
[TBL] [Abstract][Full Text] [Related]
29. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
Balachandar S; La Quaglia M; Tuttle RM; Heller G; Ghossein RA; Sklar CA
Thyroid; 2016 Feb; 26(2):219-26. PubMed ID: 26854950
[TBL] [Abstract][Full Text] [Related]
30. Follicular variant of papillary thyroid carcinoma: distinct biologic behavior based on ultrasonographic features.
Rhee SJ; Hahn SY; Ko ES; Ryu JW; Ko EY; Shin JH
Thyroid; 2014 Apr; 24(4):683-8. PubMed ID: 24341498
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
32. Should small papillary thyroid cancer be observed? A population-based study.
Nilubol N; Kebebew E
Cancer; 2015 Apr; 121(7):1017-24. PubMed ID: 25425528
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
34. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
[TBL] [Abstract][Full Text] [Related]
35. Pediatric papillary thyroid cancer >1 cm: is total thyroidectomy necessary?
Nice T; Pasara S; Goldfarb M; Doski J; Goldin A; Gow KW; Nuchtern JG; Vasudevan SA; Langer M; Beierle EA
J Pediatr Surg; 2015 Jun; 50(6):1009-13. PubMed ID: 25819020
[TBL] [Abstract][Full Text] [Related]
36. Spinal metastases due to thyroid carcinoma: an analysis of 202 patients.
Kushchayeva YS; Kushchayev SV; Carroll NM; Felger EA; Links TP; Teytelboym OM; Bonichon F; Preul MC; Sonntag VK; Van Nostrand D; Burman KD; Boyle LM
Thyroid; 2014 Oct; 24(10):1488-500. PubMed ID: 24921429
[TBL] [Abstract][Full Text] [Related]
37. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
[TBL] [Abstract][Full Text] [Related]
38. Identification of Unique, Heterozygous Germline Mutation, STK11 (p.F354L), in a Child with an Encapsulated Follicular Variant of Papillary Thyroid Carcinoma within Six Months of Completing Treatment for Neuroblastoma.
Buryk MA; Picarsic JL; Creary SE; Shaw PH; Simons JP; Deutsch M; Monaco SE; Nikiforov YE; Witchel SF
Pediatr Dev Pathol; 2015; 18(4):318-23. PubMed ID: 25751324
[TBL] [Abstract][Full Text] [Related]
39. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
